JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB325926

Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527]

  • RabMAb
  • Recombinant
  • 20ul selling size
  • KO Validated
  • What is this?

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal Cyclin D1 phospho T286 antibody. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Human samples.

View Alternative Names

BCL1, PRAD1, CCND1, G1/S-specific cyclin-D1, B-cell lymphoma 1 protein, BCL-1 oncogene, PRAD1 oncogene, BCL-1

3 Images
Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)
  • WB

Lab

Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Performed under reducing conditions.

In Western blot, aab325926 was shown to bind specifically to Cyclin D1 (phospho T286). Target of interest was observed at 33 kDa in A549 treated with 10µM MG-132 for 4 hours lysates (lane 2) with no signal observed at this size in CCND1 (Cyclin D1) knockout cell line (lanes 3-4) (lanes 3-4, knockout cell line ab286759).

The identity of the bands higher than 75kda are unknown.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

All lanes:

Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (ab325926) at 1/1000 dilution

Lane 1:

Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate 20 µg (untreated membrane)

Lane 2:

A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (untreated membrane)

Lane 3:

Untreated CCND1 (Cyclin D1) knockout A549 whole cell lysate 20 µg (untreated membrane)

Lane 4:

CCND1 (Cyclin D1) knockout A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (untreated membrane)

Lane 5:

Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate 20 µg (alkaline phosphatase treated membrane)

Lane 6:

A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (alkaline phosphatase treated membrane)

Lane 7:

Untreated CCND1 (Cyclin D1) knockout A549 whole cell lysate 20 µg (alkaline phosphatase treated membrane)

Lane 8:

CCND1 (Cyclin D1) knockout A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (alkaline phosphatase treated membrane)

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 33 kDa,36 kDa

false

Exposure time: 48s

Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)
  • WB

Lab

Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

All lanes:

Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (ab325926) at 1/1000 dilution

Lane 1:

Untreated HT-1080 (human fibrosarcoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HT-1080 treated with 10µM MG-132 for 4 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 33 kDa,36 kDa

false

Exposure time: 92s

Dot Blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)
  • Dot

Lab

Dot Blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)

Dot blot analysis of Cyclin D1 using ab325926 at 1 : 10000 (0.051 µg/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.

Lane 1 : Human Cyclin D1 (phospho T286) peptide

Lane 2 : Human Cyclin D1 (non-phospho) peptide

Lane 3 : Human Cyclin D2 (phospho T280) peptide

Lane 4 : Human Cyclin D3 (phospho T283) peptide

Exposure time : 180 seconds.

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The antibody recognises CCND1 (Cyclin D1) when phosphorylated at Threonine 286, and shows weak reactivity with CCND2 (Cyclin D2) when phosphorylated at Threonine 280 by dot blot.

All lanes:

Dot Blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (ab325926) at 1/10000 dilution

Lane 1:

Human Cyclin D1 (phospho T286) peptide

Lane 2:

Human Cyclin D1 (non-phospho) peptide

Lane 3:

Human Cyclin D2 (phospho T280) peptide

Lane 4:

Human Cyclin D3 (phospho T283) peptide

Secondary

All lanes:

Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

false

Exposure time: 180s

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR30260-527

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

Dot, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The antibody recognises CCND1 (Cyclin D1) when phosphorylated at Threonine 286, and shows weak reactivity with CCND2 (Cyclin D2) when phosphorylated at Threonine 280 by dot blot. No Cyclin D2 (phospho T280) signal was observed in endogenous samples.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "Dot-species-checked": "notRecommended", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Synthetic peptide - Human": { "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/10000", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 33854235, PubMed : 8114739, PubMed : 8302605). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 8114739, PubMed : 8302605). Hypophosphorylates RB1 in early G(1) phase (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 8114739, PubMed : 8302605). Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals (PubMed : 1827756, PubMed : 1833066, PubMed : 19412162, PubMed : 8302605). Also a substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity (PubMed : 15241418). Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (PubMed : 9106657). Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner (PubMed : 16569215, PubMed : 18417529).
See full target information CCND1 pT286

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com